» Articles » PMID: 16754295

Novel Neuroprotective, Neuritogenic and Anti-amyloidogenic Properties of 2,4-dinitrophenol: the Gentle Face of Janus

Overview
Journal IUBMB Life
Date 2006 Jun 7
PMID 16754295
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In Roman mythology, Janus was the god of gates, doors, beginnings and endings. He was usually depicted with two faces looking in opposite directions. Janus was frequently used to symbolize change and transitions, such as the progression from past to future or from one viewpoint to another. 2,4-dinitrophenol (DNP) and other nitrophenols have long been known to be toxic at high concentrations (the 'bad' face of DNP), an effect that appears essentially related to interference with cellular energy metabolism due to uncoupling of mitochondrial oxidative phosphorylation. Five years ago, however, we published the first report showing that low concentrations of DNP protect neurons against the toxicity of the amyloid-beta peptide (De Felice et al. (2001) FASEB J. 15:1297 - 1299]. Since then, other studies have provided evidence of beneficial actions of DNP (at low concentrations), including neuroprotection against different types of insult, blockade of amyloid aggregation, stimulation of neurite outgrowth and neuronal differentiation, and even extension of lifespan in certain organisms. Some of these effects appear to be due to mild mitochondrial uncoupling and prevention of cellular oxidative stress, whereas other actions are related to activation of additional intracellular signaling pathways. Thus, a novel and 'gentle' face of DNP is emerging from such studies. In this review, we discuss both toxic and beneficial actions of DNP. The evidence available so far suggests that DNP and other compounds with similar biological activities may be of significant interest to the development of novel therapeutic approaches for neurodegenerative diseases and other neurological disorders.

Citing Articles

Micro-Doses of DNP Preserve Motor and Muscle Function with a Period of Functional Recovery in Amyotrophic Lateral Sclerosis Mice.

Zhong R, Dionela D, Kim N, Harris E, Geisler J, Wei-LaPierre L Ann Neurol. 2024; 97(3):542-557.

PMID: 39552508 PMC: 11831883. DOI: 10.1002/ana.27140.


Targeting mitochondrial Ca uptake for the treatment of amyotrophic lateral sclerosis.

Zhong R, Rua M, Wei-LaPierre L J Physiol. 2023; 602(8):1519-1549.

PMID: 38010626 PMC: 11032238. DOI: 10.1113/JP284143.


Mitochondria exert age-divergent effects on recovery from spinal cord injury.

Stewart A, McFarlane K, Vekaria H, Bailey W, Slone S, Tranthem L Exp Neurol. 2021; 337:113597.

PMID: 33422552 PMC: 7870583. DOI: 10.1016/j.expneurol.2021.113597.


Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis.

Patoli D, Mignotte F, Deckert V, Dusuel A, Dumont A, Rieu A J Clin Invest. 2020; 130(11):5858-5874.

PMID: 32759503 PMC: 7598049. DOI: 10.1172/JCI130996.


Energy Metabolism and Redox State in Brains of Wistar Audiogenic Rats, a Genetic Model of Epilepsy.

Dechandt C, Ferrari G, Dos Santos J, Cortes de Oliveira J, da Silva-Jr R, Cunha A Front Neurol. 2019; 10:1007.

PMID: 31632331 PMC: 6781615. DOI: 10.3389/fneur.2019.01007.